Retatrutide, developed by Soma Pharmaceuticals , represents a promising breakthrough in body regulation. This unique drug combines hormonal receptor agonist properties with GIP pathway stimulation , demonstrating remarkable efficacy in clinical studies for weight loss . Researchers believe the dr